Scilex Holding Co SEC filings SCLXW

Scilex Holding Co has 742 filings in SEC EDGAR's recent list, going back to Aug 19, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
10-K Annual report Apr 10, 2026 Dec 31, 2025
ARS Annual report to shareholders May 16, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Mar 12, 2024 Dec 31, 2023
10-K Annual report Mar 12, 2024 Dec 31, 2023
ARS Annual report to shareholders Mar 13, 2023 Dec 31, 2022
10-K Annual report Mar 7, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SCLX (Nasdaq), SCLXW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
, Emerging growth company
SEC CIK
1820190
Former names
Scilex Holding Company/DE (until Nov 30, 2022); Vickers Vantage Corp. I (until Nov 15, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.